XTX Topco’s Sana Biotechnology SANA Stock Holding History

XTX Topco’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$791K	Buy	226,590 +116,280	+105%	+$375K	0.01%	2017
2026 Q1	$318K	Sell	110,310 -7,066	-6%	-$27.8K	0.01%	2439
2025 Q4	$478K	Buy	117,376 +10,581	+10%	+$47.4K	0.01%	1641
2025 Q3	$379K	Buy	+106,795	New	+$386K	0.02%	1309
2025 Q1	–	Sell	-175,167	Closed	-$286K	–	3009
2024 Q4	$286K	Buy	+175,167	New	+$522K	0.02%	1265
2024 Q3	–	Sell	-18,249	Closed	-$99.6K	–	2537
2024 Q2	$99.6K	Buy	+18,249	New	+$145K	0.01%	1420
2024 Q1	–	Sell	-30,282	Closed	-$124K	–	2264
2023 Q4	$124K	Buy	+30,282	New	+$112K	0.03%	1087
2023 Q3	–	Sell	-10,081	Closed	-$60.1K	–	1959
2023 Q2	$60.1K	Sell	10,081 -3,137	-24%	-$18.1K	0.01%	1220
2023 Q1	$43.2K	Sell	13,218 -71,925	-84%	-$287K	0.01%	1182
2022 Q4	$336K	Buy	+85,143	New	+$416K	0.07%	515
2022 Q2	–	Sell	-10,406	Closed	-$86K	–	1072
2022 Q1	$86K	Buy	+10,406	New	+$84.1K	0.04%	535

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

XTX Topco's SANA Position: Q2 2026 in Review

XTX Topco increased its Sana Biotechnology (SANA) stake by 105% in Q2 2026, buying an estimated $375K and bringing the position to 226,590 shares worth $791K. The position accounts for 0.01% of the portfolio, ranked #2017.

XTX Topco first reported a position in SANA in Q1 2022 and has held it in 11 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

XTX Topco held 226,590 shares of Sana Biotechnology worth $791K as of Q2 2026.
XTX Topco bought 116,280 Sana Biotechnology shares in Q2 2026, an estimated $375K.
Sana Biotechnology made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2017 holding.
XTX Topco first reported a position in Sana Biotechnology in Q1 2022 and has held it in 11 quarters since.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.